In summary, our findings highlight that USP21-mediated post-translational regulation of HSP90 and ENO1 is important in aerobic glycolysis and CCA tumor progression and provide an option for cancer therapy targeting glucose metabolism. This evidence concerns the gene ENO1 and cancer.